We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6.16%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25B
AUM Growth
+$2.37B
(+11%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$783M |
| 2 |
Genuine Parts
GPC
|
+$573M |
| 3 |
Paychex
PAYX
|
+$431M |
| 4 |
Monster Beverage
MNST
|
+$119M |
| 5 |
Northern Trust
NTRS
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$804M |
| 2 |
Accenture
ACN
|
+$118M |
| 3 |
Sysco
SYY
|
+$76.9M |
| 4 |
Apple
AAPL
|
+$76.7M |
| 5 |
NetApp
NTAP
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
State Street
STT
$51.2B
| $4.53M | 0.02% |
54,102
-31,038
| -36% | -$2.73M |
|
452
Louisiana-Pacific
LPX
$5.39B
| $4.52M | 0.02% |
+170,796
| New | +$4.87M |
|
453
Tetra Tech
TTEK
$8.27B
| $4.51M | 0.02% |
330,535
+725
| +0.2% | +$9.6K |
|
454
Arrow Electronics
ARW
$10.9B
| $4.49M | 0.02% |
60,900
-1,559
| -2% | -$120K |
|
455
Vanguard Mid-Cap ETF
VO
$107B
| $4.48M | 0.02% |
+109,160
| New | +$4.45M |
|
456
Danaher
DHR
$135B
| $4.47M | 0.02% |
46,435
-3,850
| -8% | -$351K |
|
457
Hyatt Hotels
H
$18B
| $4.3M | 0.02% |
54,065
-201,388
| -79% | -$15.8M |
|
458
Micron Technology
MU
$1.04T
| $4.3M | 0.02% |
95,027
-2,254
| -2% | -$114K |
|
|
WDR
459
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4.24M | 0.02% |
199,987
+54,880
| +38% | +$1.1M |
|
460
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $4.2M | 0.02% |
11,436
-8,303
| -42% | -$3.04M |
|
461
Zimmer Biomet
ZBH
$17.9B
| $4.14M | 0.02% |
32,435
-276
| -0.8% | -$32.8K |
|
462
Cincinnati Financial
CINF
$28.5B
| $4.12M | 0.02% |
53,631
+4,391
| +9% | +$327K |
|
463
Old Republic International
ORI
$10.5B
| $4.11M | 0.02% |
183,755
-3,152
| -2% | -$68K |
|
464
ON Semiconductor
ON
$34.7B
| $4.08M | 0.02% |
221,363
+32,714
| +17% | +$699K |
|
465
United Therapeutics
UTHR
$26.6B
| $4.05M | 0.02% |
31,657
-20,742
| -40% | -$2.57M |
|
466
Carnival Corporation Ltd
CCL
$37.6B
| $3.99M | 0.02% |
62,581
+6,517
| +12% | +$395K |
|
467
STMicroelectronics
STM
$47.5B
| $3.92M | 0.02% |
213,656
+70,825
| +50% | +$1.47M |
|
468
PBF Energy
PBF
$7.29B
| $3.81M | 0.02% |
76,440
| – | – |
|
469
iShares S&P Small-Cap 600 Value ETF
IJS
$8.2B
| $3.79M | 0.02% |
+45,450
| New | +$3.84M |
|
470
Crown Castle
CCI
$32.5B
| $3.74M | 0.02% |
33,589
+2,462
| +8% | +$274K |
|
|
XIFR
471
XPLR Infrastructure LP
XIFR
$1.19B
| $3.7M | 0.01% |
76,399
-900
| -1% | -$42.7K |
|
472
CNA Financial
CNA
$14.6B
| $3.68M | 0.01% |
80,640
| – | – |
|
473
Northrop Grumman
NOC
$77.7B
| $3.66M | 0.01% |
11,548
+1,771
| +18% | +$540K |
|
|
SYKE
474
DELISTED
SYKES Enterprises Inc
SYKE
| $3.64M | 0.01% |
119,484
+304
| +0.3% | +$9.06K |
|
475
Ingredion
INGR
$6.39B
| $3.57M | 0.01% |
33,981
-3,625
| -10% | -$370K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2018 Portfolio in Review
As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.
- Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
- Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
- Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
- Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
- Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
- Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
- Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.
Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.